B6Z-32842-47588
4 vaccinations
9 coded responses
51 check-ins
7 free-text entries
10 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 721 / AR
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
Q4B-11059-26357
Child or adolescent in my care · Male · 2022-07-02
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2020-12-19
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2020-12-20
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Office visit, Urinary tract infection — Feeling: Poor · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to work, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Severe UTI per urgent care, at ER with poss pyelonephritisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-23
Health check-in — day 7, dose 1Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-23
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-23
Call successfulParticipant prefers to complete VAERS report online
-
2020-12-23
Call successfulParticipant prefers to complete VAERS report online
- 2020-12-30
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities2 call case(s)
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-19
- 2021-01-26
- 2021-02-02
-
2021-02-09
Survey response — day 35, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Previously diagnosed with pots having worse flaresMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-16
-
2021-04-06
Survey response — 3 months, dose 2MedDRA: Syncope — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: New dx of neurocardiogenic syncopeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
- 2021-06-08
- 2021-07-06
-
2021-09-30
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
-
2021-10-21
Survey response — day 21, dose 3MedDRA: Pyrexia, Weight decreased — Feeling: GoodFree text: Significant weight loss (>25Ibs), intermittent feversMedDRA releases: 2024-11 · check-in free text available
- 2021-10-28
-
2021-11-04
Survey response — day 35, dose 3MedDRA: Fatigue, Increased tendency to bruise, Weight decreased — Feeling: Good · Be unable to do your normal daily activitiesFree text: Extreme fatigue, easy bruising, some weight lossMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Survey response — day 42, dose 3MedDRA: Gastrointestinal viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Severe gi bugMedDRA releases: 2024-11 · check-in free text available
- 2021-12-30
- 2022-03-31
-
2022-08-09
Call successfulParticipant prefers to complete VAERS report online
-
2022-08-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-08-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-30
Survey response — 12 months, dose 3MedDRA: Oesophagogastroduodenoscopy abnormal, Ulcer — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Diagnosed yesterday with an ulcer per EGD. Cultures and biopsies are pending.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-10-05
-
2022-11-04
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-04
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2022-12-19
-
2023-02-03
Survey response — 3 months, dose 4MedDRA: Bronchitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-03
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-06
- 2023-02-06
-
2023-05-07
Survey response — 6 months, dose 4MedDRA: Systemic scleroderma — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-05-07
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-05-08
- 2023-05-08
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | Flu |
| 4 | 2022-11-04 | Pfizer-BioNTech | Flu |
Call center
10 call center cases
5 successful · 3 unsuccessful · 2 priority 2/3 (triaged and no follow up)
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Severe UTI per urgent care, at ER with poss pyelonephritis
Release 3 — day 35, dose 2
Symptoms: Previously diagnosed with pots having worse flares
Release 7 — 3 months, dose 2
Symptoms: New dx of neurocardiogenic syncope
Release 10 — day 21, dose 3
Symptoms: Significant weight loss (>25Ibs), intermittent fevers
Release 10 — day 35, dose 3
Symptoms: Extreme fatigue, easy bruising, some weight loss
Release 10 — day 42, dose 3
Symptoms: Severe gi bug
Release 12 — 12 months, dose 3
Symptoms: Diagnosed yesterday with an ulcer per EGD. Cultures and biopsies are pending.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Increased tendency to bruise | · | · | ✓ |
| SD | Oesophagogastroduodenoscopy abnormal | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Syncope | ✓ | ✓ | ✓ |
| SD | Systemic scleroderma | · | · | ✓ |
| SD | Ulcer | · | · | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SRO | Emergency care | ○ | ○ | ○ |
| SRO | Office visit | ✓ | ✓ | ✓ |
| SRO | Urinary tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release